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Cerebral Vascular Tone Regulation: 
Integration and Impact of Disease
Brayden Halvorson and Jefferson Frisbee
Abstract
This chapter summarizes the current knowledge regarding the regulation of 
the tone of cerebral resistance arteries under conditions of normal health and 
with the development of chronic diseases (e.g., metabolic disease). The work 
integrates the myogenic (pressure-induced) regulation of vascular tone, the impact 
of elevated luminal flow or shear stresses, that of local tissue metabolic activity on 
vascular tone and the concept of neurovascular coupling (linking neuronal activity 
to the impacts on vascular diameter). In addition, this work summarizes some of 
the recent work on how diseases such as type 2 diabetes impact the mechanisms 
of cerebrovascular tone regulation. It is anticipated that the current review will 
provide the reader with an up-to-date understanding of how the cerebral resistance 
vessels respond to changes in their local environment and contribute to the regula-
tion of blood flow within the brain.
Keywords: cerebral, perfusion resistance, metabolic disease, vascular function, 
vascular disease risk
1. Introduction
The brain has a remarkably high metabolic rate and thus requires a highly dis-
proportional amount of blood flow. Although its only 2% of body weight, the brain 
takes up 15–20% of cardiac output [1], making it one of the most highly perfused 
organs in the human body. This high metabolic rate coupled with its limited capacity 
for energy storage [2] necessitates heavy reliance on oxidative metabolism and thus 
requires constant blood flow to maintain nutrient and oxygen supply, remove waste 
products, and maintain a state of cerebral metabolic homeostasis. Severe underper-
fusion can quickly result in unconsciousness [3] and if prolonged, death [4]; while 
chronic mild under perfusion is associated with cognitive decline [5]. In addition to 
its high perfusion and metabolic rate, the cerebral circulation faces a unique chal-
lenge of being enclosed in the skull. This rigid structure prevents the expansion of 
tissue and extracellular fluid. Swelling within the skull from vasogenic edema leads 
to an increase in intracranial pressure which in turn can lead to neurologic compli-
cations or in more extreme cases death [1]. The unique challenges of the cerebral 
circulation, including intolerance to ischemia and edema, coupled with the para-
mount importance of maintaining constant nutrient and oxygen supply to cerebral 
tissue creates a need for precise regulation of cerebral blood flow and therefore the 
presence of redundant intrinsic mechanisms for its regulation. The anatomy of the 
brain vasculature ensures multiple routes for blood and oxygen delivery potentially 
allowing for perfusion even in cases of a blocked blood vessel [6]; however, acute 
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regulation of flow is done primary by altering the diameter of blood vessels, and 
thus the resistance to flow. The major mechanisms of local regulation of vascular 
tone intrinsic to the cerebral vasculature include myogenic, shear, and metabolic 
based regulation. Although each mechanism has a discrete effect on vascular tone 
the integration of the different contributors to determine an appropriate level of 
tone is much more difficult to discern, especially in the cerebral circulation. These 
complex interactions allow for highly accurate control of cerebral blood flow in addi-
tion to protecting vulnerable downstream capillaries from high pressures and flow 
rates that could otherwise lead to edema; but, they also introduce several potential 
areas for failure. The intimate interactions of the various mechanisms of regulation 
of flow mean that the failure of one mechanism has the potential to initiate a cascade 
of events that results in inappropriate regulation of flow. As such abnormal execu-
tion of vascular tone regulation may form the basis of vascular pathologies [7].
One of these pathologies with a significant vascular component associated 
with impaired cerebral vascular tone regulation is metabolic syndrome (MetS). 
The incidence and prevalence of MetS is growing in Western society [8–10] and 
is contributing to decreased quality of life and increased economic burden. Thus 
an understanding of how it alters the cerebral circulation is crucial. MetS is cat-
egorized by a collection of metabolic risk factors including obesity, hypertension, 
atherogenic dyslipidemia and impaired glycemic control creating a pro-oxidant 
pro-inflammatory environment that raises the risk of developing impaired vascular 
structures and function [11–14]. These impairments are particularly detrimental 
when they affect the cerebral circulation and lead to cerebrovascular pathologies 
such as stroke or transient ischemic attack (TIA) due to the detrimental conse-
quences associated with such events. However, cognitive impairments are not lim-
ited to individuals that have experienced an acute ischemic event since even in their 
absence MetS is strongly associated with impaired cognitive function and decreased 
quality of life [15–18]. Therefore preventing their occurrence by protecting the 
cerebrovasculature from functional and structural decline is paramount. This 
chapter will present a description of the local mechanisms involved in the regula-
tion of cerebral vascular tone, how they integrate with one another and how they 
can be compromised in disease. Although impairments to the regulation of cerebral 
vascular tone are not limited to conditions associated with MetS this discussion will 
focus on the impact of MetS and its associated risk factors.
2. Myogenic mechanism
The myogenic mechanism which was first described by Bayliss is an intrinsic 
property of the vascular smooth muscle to respond to changes in intravascular pres-
sure which is independent of other mechanisms of tone regulation including neural, 
metabolic, and hormonal influences [19]. The intrinsic nature of the myogenic 
response is supported by its existence in arteries and arterioles that have been 
sympathetically denervated and had their endothelium removed [20] thus leaving 
only the vessel itself to initiate and execute the response. The prototypical response 
of the vascular smooth muscle in response to an increase in intraluminal pressure 
is initial distension quickly followed by a constriction. The opposite can be said in 
situations of decreased intraluminal pressure; a fall in intraluminal pressure results 
in vessel collapse followed by dilation [21]. The myogenic response has several 
physiological roles including the establishment and maintenance of basal vascular 
tone (some degree of constriction) so that resistance may be increased or decreased 
by metabolic vasoconstrictors or vasodilators respectively, in order to regulate tissue 
perfusion. The establishment and maintenance of this partially constricted state 
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in a pressurized vessel is referred to as myogenic tone. Additionally, the myogenic 
tone has a role in flow and pressure regulation. It functions by constricting to drop 
the pressure that reaches the downstream capillaries and protect them from edema 
or vascular remodeling associated with hypertension in the capillaries [22–25]. 
Equally important as protecting from hypertension is the ability of the vasculature 
to promote flow during low pressure by dilating. This ability to alter diameter over 
a range of pressures is referred to as myogenic reactivity. Beyond the local implica-
tions for the regulation of vascular tone, resistance to flow also has implications for 
systemic blood pressure since mean arterial pressure is the product of total periph-
eral resistance and cardiac output. This relationship illustrates system-wide impli-
cations of accurate vascular tone regulation. While the myogenic response is present 
throughout the body in a variety of vessels (arterioles, veins, lymphatic vessels) [26] 
the aforementioned functions of the myogenic response are particularly important 
in the cerebral circulation due to the catastrophic outcomes associated with under 
or over perfusion including unconsciousness and edema respectively. It is therefore 
not surprising that the most prominent myogenic response is found in the cere-
bral circulation with arterioles (resistance vessels) having the most pronounced 
response [1]. It should also be noted that the large arteries feeding the brain have 
a greater contribution to regulating vascular resistance in the cerebral circulation 
compared to other vascular beds, again providing evidence for the importance of 
regulating tone in the cerebral circulation.
A phase model of arterial myogenic behavior is commonly used to describe the 
response over a range of pressure. In the first phase, there is an initial development 
of myogenic tone at approximately 40–60 mmHg with increasing pressure up to 
that point causing passive distension. There is then a phase of myogenic reactivity 
in the pressure range of 60–140 mmHg and finally a phase of forced dilation at 
transmural pressures greater than approximately 140 mmHg [27].
2.1 Myogenic tone
Myogenic tone develops at approximately 40–60 mmHg and is characterized 
by an increase in intracellular Ca2+, of about 200%, followed by a reduction in 
lumen diameter. This pressure causes cellular deformation, depolarization of the 
vascular smooth muscle cells (VSMC), and a significant increase in wall tension. 
Wall tension appears to be the controlled parameter in the myogenic response 
which is altered during an increase or decrease in transmural pressure. The myo-
genic response adjusts the diameter of the vessel in an attempt to restore or limit 
the change in basal wall tension through a negative feedback mechanism [28, 29]. 
The suggestion that wall tension is the controlled parameter is supported by its 
correlation with changes in cell calcium and myosin light-chain phosphorylation, 
a relationship that is not seen with vessel diameter [30, 31].
The mechanism of the myogenic response is attributed to stretch-activated ion 
channels: including L-type calcium channels, voltage-activated calcium channels 
and calcium activated potassium channels along with enzymatic mechanisms. 
Specifically, increased intraluminal pressure causes depolarization of the VSMC 
membrane and calcium influx by the opening of voltage-gated calcium channels 
(VGCCs), with the most prominent involvement being from CaV1.2. This influx 
of Ca2+ leads to increased myosin light-chain (MLC) phosphorylation which 
promotes increased actin/myosin interaction followed by cross-bridge cycling and 
cell shortening (vasoconstriction) [7, 24, 32–34]. The importance of Ca2+ influx 
in the generation of myogenic tone supported by its complete abolishment under 
Ca2+ free conditions [32, 35]; this is also a technique frequently used to study the 
passive mechanical characteristics of vessels to determine the degree of vascular 
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remodeling since the VMSC exhibit a passive response (no force production) its 
strain is only due to the applied stress applied and the composition of the vessel 
[36]. Under physiological conditions the magnitude of the constrictor response to 
increased intraluminal pressure is limited by calcium-activated potassium chan-
nels that carry hyperpolarizing current proportional to the intracellular calcium 
concentration [35]. This negative feedback mechanism is supported by enhanced 
myogenic constriction being observed following blockade of calcium-activated 
potassium channel by specific inhibitors of these channels [37–39]. Additionally, 
at this pressure of 40–60 mmHg there is an activation of enzymatic systems and 
a complex interaction between matrix metalloproteins, the extracellular matrix, 
integrins and the cytoskeleton [40–42] that contribute to the myogenic reactiv-
ity at higher intraluminal pressures within the range of 60–140 mmHg [27]. This 
myogenic tone phase can also be characterized as the lower limit of autoregulation, 
which has important physiological implications. Below this pressure blood flow 
becomes dependent on blood pressure since the vessel cannot further dilate and 
begins to collapse as the pressure drops below this point [43]. Having an appropriate 
lower limit becomes especially important in situations of cerebral ischemia to allow 
restoration of flow in the presence of hypotension.
2.2 Myogenic reactivity
In this range of intraluminal pressure of 60–140 mmHg where the myogenic tone 
has already been established increases in pressure generally result in mild constric-
tion and decreased pressure leads to mild dilation. Just as previously discussed for the 
generation of myogenic tone, increased pressure within this range leads to stretch, 
depolarization, and constriction of the vascular smooth muscle. However, in the 
myogenic reactivity phase, there is little change in vessel diameter across the range 
of pressures along with relatively small increases in Ca2+ (<20%) despite sizable 
increases in force production [27]. Multiple studies suggest an increased sensitivity 
to Ca2+ compared to the previous phase in the development of myogenic tone [20, 27, 
44–48]. Increased sensitivity to Ca2+ is achieved by inhibition of myosin light chain 
phosphatase (MLCP) which promotes the accumulation of phosphorylated LC20 
without an accompanying increase in calcium-induced myosin light chain kinase 
activity [49]. The presence of a contractile mechanism that does not require large 
variation of calcium, such as altering Ca2+ sensitivity requires less storage and trans-
membrane shuttling and is therefore advantageous in terms of conserving Ca2+ [35].
There are several proposed mechanisms that regulate Ca2+ sensitivity within this 
phase including, activation of protein kinase C (PKC), RhoA/Rho kinase pathways, 
and reactive oxygen species (ROS) [27, 35, 44, 46, 50]. The following studies provide 
evidence for the aforementioned mechanisms of enhanced Ca2+ sensitivity in this 
phase of the myogenic response through the utilization of specific inhibitors or trans-
genic animal models. Inhibition of PKC stops myogenic vasoconstriction in middle 
cerebral arteries with no impact on pressure-induced Ca2+ elevation [46]. Direct 
assessment of Ca2+ sensitivity by measuring the Ca2+-tone relationship has consis-
tency found decreased sensitivity during Rho kinase inhibition [20, 45]. ROK has also 
been reported to trigger smooth muscle depolarization during myogenic constriction 
and limit the extent of depolarization by opening delayed rectifier potassium channels 
[51, 52]. Arteries from transgenic animals missing NADPH oxidase function show an 
absence of myogenic activity [53], while mice deficient in superoxide dismutase, an 
endogenous antioxidant enzyme that catalyzes the breakdown of superoxide radical 
to H2O2, acquired enhanced myogenic reactivity [54]. Additional mechanisms that 
contribute to the myogenic reactivity phase independent of Ca2+ sensitivity include 
actin cytoskeleton reorganization and thin filament regulation [55, 56].
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2.3 Forced dilation
Although the prototypical response of increased intraluminal pressure is a 
constriction, at excessively high pressures, beyond the autoregulatory range of 
approximately 140 mmHg, forced dilation often occurs [57]. This process results 
in a loss of myogenic tone, and thus results in an increase in vessel diameter, rapid 
increase in wall tension and significant elevation in Ca2+ (>50%) [27]. Although 
the name implies a degree of passiveness in the process, forced dilation is likely an 
active vasodilation involving KCa channels, nitric oxide (NO) and or ROS, which 
are activated to protect the arterial wall from damage [44, 57]. If the pressure 
is reduced to within the myogenic reactivity range reestablishment of tone and 
 reduction in Ca2+ is observed.
3. Response to flow (shear stress)
An increase in flow leads to an increase in a frictional force known as shear that 
is detected by the endothelial cells lining the vessel lumen as blood moves through a 
vessel. As such, the magnitude of the shear force is proportional to blood flow. Shear 
catalyzes physiologically important responses in the cerebral vasculature such as 
encouraging reperfusion after ischemia, aiding in the hyperemic response to increased 
metabolic demand, and perhaps protection of downstream capillaries from edema 
and structural damage. Flow has been found to induce both constrictor and dilator 
pathways that act on the VSMC and result in a final level of tone taking into account 
the opposing processes. It is generally accepted that in the peripheral circulation flow 
leads to dilation; however, in the cerebral circulation the response is more contro-
versial with both constriction and dilation being reported. These opposing observa-
tions may be because of a variety of factors including the area of the brain studied, 
the preparation used or because of interactions with other mechanisms affecting 
cerebral vascular tone. Within the cerebral circulation, the vertebrobasilar systems 
appear to elicit flow-mediated dilation, as measured in rats and mice [58] and humans 
[59]. The increase in flow is sensed by the endothelium, which initiates a negative 
feedback mechanism in an attempt to decrease the shear stress by dilating. Shear-
induced dilation is largely endothelium-dependent and is at least partially mediated 
by NO [60]. The production of NO is controlled by the enzyme nitric oxide synthase 
(NOS), particularly endothelial NOS (eNOS), which catalyzes the formation of NO 
from L-arginine and is itself dependent on phosphorylation by Akt [61, 62]. The NO 
formed by eNOS then diffuses into the vascular smooth muscle where it activates 
soluble guanylyl cyclase (sGC) and increases cyclic guanine monophosphate (cGMP) 
and activating protein kinase G [63, 64]. Activation of protein kinase G opens large-
conductance Ca2+-activated K+ (BKCa) channels reducing intracellular Ca2+ which 
leads to relaxation of the vascular smooth muscle and thus vasodilation [65]. In addi-
tion to NO, eNOS can also lead to the formation of H2O2 which may also mediate flow-
induced dilation [18]. During enzymatic cycling, eNOS produces oxygen radicals [66, 
67] which, in the presence of sufficient antioxidants, are converted into H2O2 that may 
then, like NO, activate sGC and lead to dilation [68]. Other endothelium-dependent 
dilators such as prostaglandins do not appear to be involved in shear-induced dilation 
since the COX inhibitor indomethacin had no effect on the response to flow [60].
Constriction of cerebral vessels has also been reported in cats [69], rats [70] and 
human isolated cerebral arteries [71]. Constriction appears to predominate within 
the carotid circulatory area [58] especially when studies using ex vivo isolated 
vessels. In contrast to the dilator response, flow-induced constriction occurs 
independent of the endothelium [72, 73]. Although the mechanics for constriction 
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in response to increased flow is not fully understood it appears to be mediated 
in part by a combination of integrin signaling, free radicals, and tyrosine kinase. 
Giving integrin-binding peptides, scavenging ROS by superoxide dismutase (SOD) 
or inhibiting tyrosine [69] all significantly reduced or eliminated constriction in 
response to flow. Just as in flow-induced dilation shear stress appears to be the 
initiating parameter in flow induced constriction whose force can be transduced by 
integrin signaling [69]. Additionally, Koller and Toth found that flow-induced con-
striction of cerebral vessels were blocked by inhibiting the synthesis of 20-HETE, 
thromboxane A2 receptor, COX activity, and scavenging ROS. From that, they 
proposed that increase flow activates an AA cascade with metabolism by CYP450 
4A enzymes resulting in the production of 20-HETE and ROS which contribute to 
the constriction via thromboxane A2/prostaglandin H2 receptors [71].
The differences in observed responses may also be dependent on whether the 
study was conducted in vivo or ex vivo. Ex vivo studies typically use a physiologic 
salt solution that has a much lower viscosity than blood and may be inadequate 
to stimulate the endothelium to produce endothelium-dependent dilation [74]. 
Consequently, the ex vivo responses to intraluminal shear have been shown to be 
endothelium-independent [69, 72]. Furthermore, ex vivo study generally lack pulsa-
tile flow pumps but those that have been able to employ peristaltic or piston pump 
have indicated a role for shear-mediated regulation [68, 75, 76]. In contrast, in vivo 
study has produced more consistent shear-mediated dilation [62, 77]. Raignault 
et al. showed in a mouse model that the cerebrovascular endothelium optimally 
integrates shear stress to eNOS-mediated dilation under physiological pulse pres-
sures, a phenomenon that was not seen in static flow conditions [76]. It appears that 
cerebral arteries are more responsive to a pulsatile environment with a viscose fluid 
(blood) as is experienced in vivo and consequently able to dilate in response to shear 
stress through endothelium-dependent production of NO [68, 76, 78].
Although flow induced constriction is not usually seen in vivo at high flow rates 
it may play a protective role in the cerebral circulation. Just as low flow situa-
tions are dangerous, especially in the brain, so too are instances of extreme flow; 
therefore it is important to have multiple regulatory mechanisms that are able to 
attenuate an increase in flow as a protective mechanism for the cerebral circulation 
from high volumes [1, 79, 80]. It is advantageous for the response to flow to adapt 
in accordance with other inputs on the regulation of vascular tone. This may be the 
reason why characterizing the response to flow in the cerebral circulation has been 
variable. One variable that may alter the response to flow is the absolute rate of flow. 
In isolated branches of MCA from rats vessels dilated with flow up to 10 μL/min but 
their diameter constricted back to baseline at higher levels of flow [81]. Shimoda 
et al. also found a biphasic flow-dependent response in anterior and middle cerebral 
arteries of neonatal pigs; flow rates between 0.077 and 0.212 mL/min constricted 
vessels while dilation occurred at higher flow rates up to 1.6 mL/min [82].
3.1 Flow and pressure
In a physiological setting multiple inputs are being processed by the cerebral 
vasculature leading to the generation of a certain level of tone. Pressure and shear 
stress exerted by flowing blood are two mechanical stimuli that have been described 
to play a major role in the regulation of vascular tone [83, 84]. It is therefore impor-
tant to consider their interaction when determining the resultant effect on vascular 
tone. At high pressures (around >80 mmHg) cerebral vessels tend to constrict in 
response to flow [72, 85–87]. This biphasic response is further supported by find-
ings from Garcia-Roldan and Bevan in isolated rabbit pial arterioles with flow rates 
from 0 to 20 μL/min at 90 mmHg but did not with the same flow at 60 mmHg [72]. 
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It is interesting that the tipping points for “high” and “low” pressures observed in 
previous studies are around 80 mmHg since, in resistance arterioles such as the MCA 
this pressure is commonly measured under physiological conditions. If 80 mmHg is 
indeed the point where higher pressures lead to constriction and lower to dilation in 
response to shear the resistance arterioles that are resting around this pressure would 
have the opportunity to tightly regulate the response to flow and shear thus allowing 
for precise control of cerebral blood flow. Please see Figure 1 for a schematic repre-
sentation of how flow and intravascular pressure can impact cerebral vascular tone.
4. Metabolic control
The mechanical stimuli of pressure and flow are generally thought to be important 
in setting the basal vascular tone so that metabolic influences are able to cause dilation 
or constriction depending on the needs of the cerebral tissue [24]. Metabolic control 
of vascular resistance is of particular importance in the cerebral circulation since 
cerebral tissue is extremely intolerant to ischemia [88]. As such, the cerebral circula-
tion has a precise and highly localized coupling between the metabolic requirements 
of cerebral tissue and the magnitude of blood flow by controlling vascular resistance. 
There are numerous vasoactive metabolites that contribute to the control of cerebral 
vascular tone including adenosine, CO2, H
+, O2 and K
+. Increasing concentrations of 
adenosine, CO2, H
+, and K+ and decreased concentration of O2 result in relaxation of 
VSM and dilation of cerebral resistance vessels. Each metabolite is associated with a 
cascade of events that ultimately either alters intracellular Ca2+ concentration or Ca2+ 
sensitivity of the VSM and results in a change in vessel diameter. Although the effects 
of each metabolite have been well characterized the relative importance of each along 
with its interaction with each other and other parameters of tone remains an area of 
further investigation. The discussion below is summarized in Figure 1.
Figure 1. 
A schematic representation of how intravascular pressure (myogenic), increased lumen flow rates (shear), 
tissue metabolism and neurovascular coupling can impact cerebral vascular tone regulation.
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4.1 Adenosine
Adenosine has been proposed as being the primary metabolite controlling 
metabolic regulation of cerebral vascular tone. It is a naturally occurring nucleoside 
produced as a byproduct of ATP metabolism; thus, its accumulation signals a need for 
increased blood flow to match the metabolic activity. This relationship with metabo-
lism has widely implicated adenosine in local regulation of cerebral vascular tone 
during functional hyperemia, ischemia, or whenever PO2 becomes limited [89–91]. 
Adenosine has direct effects on the vasculature [92, 93] that can both vasodilate 
and hyperpolarize VSM and is therefore considered an EDHF [94]. There are four 
distinct subtypes of adenosine receptors; however, the A2A receptor appears to be of 
high importance in mediating vasodilation [95–97]. The A2A receptor is a purinergic 
P1 receptor that has been confirmed to be present in cerebral microvessels [98–101] 
on the VSM cells [102, 103]. It causes dilation in a concentration-dependent manner 
[101, 104] once bound to the A2A receptor by activation of adenylate cyclase [105] and 
therefore cAMP [106–108] which reduces cytosolic calcium and leads to vasodilation. 
The opening of KATP channels also occurs secondary to the increase in cAMP levels as a 
result of adenosine binding to its receptors on the cell membrane [109–112]. The con-
tribution of opening KATP channels to dilation is likely substantial since during block-
ade of KATP channels with glibenclamide, adenosine-induced dilation was reduced by 
approximately 50% [113]. Although A2A receptors are generally considered the most 
important mediators of the effects of adenosine on vascular tone the A2B receptors 
are also proposed to cause dilation through similar mechanisms as A2A in addition to 
coupling to Gq proteins to produce Ca2+ mobilization by activation of phospholipase C 
and mitogen-activated protein kinase activation [98, 114, 115]. In addition to dilat-
ing the cerebral vasculature adenosine may also block vasoconstrictive signals in the 
parenchyma as evidenced by in vitro data from Gordon et al. [116]. When adenosine 
receptors are blocked with theophylline dilation was attenuated to arterial hypoxia 
[117]. Similarly the competitive adenosine receptor antagonist aminophylline causes a 
20–30% decrease in CBF and cerebral oxygen delivery in normoxia [118].
4.2 PCO2
Similar to many of the other metabolites discussed CO2 tends to increase under 
conditions of increased metabolism without adequate flow to eliminate it from the 
area of production and thus its accumulation leads to dilation of the vasculature. High 
sensitivity to PCO2 is unique to the cerebral circulation [119] causing approximately 
3–6% increase and 1–3% decrease in flow per mmHg change in PaCO2 above or below 
eupnoeic PaCO2 respectively. This high sensitivity is seen throughout the arterial side 
of the vascular network including the large arteries in the neck [120] and large intra-
cranial arteries [121–123] to the smallest pial arterioles [124] and parenchymal vessels 
[125–128]. There are likely several redundant mechanistic contributors to the sensi-
tivity of the vasculature to PCO2 which may contribute to the debate as to whether 
the dilation is triggered by increased PCO2 or rather the accompanying increase H
+ 
concentration from the carbonic anhydrase reaction. There is strong support that the 
change in PCO2 mediates at least in part alterations in cerebral vascular tone locally 
by changes in perivascular pH [107, 129–131] as evidenced by acidic and alkaline 
perfusate administered through an intracranial window. Experiments that have been 
able to alter pH and PCO2 independently have provided evidence of the dependence 
of altered pH to initiate a change in cerebral vascular tone [74]. In a cat pial arteriole 
cranial window preparation, lowering pH along with hypercapnia resulted in no 
difference in the magnitude of vasodilation when compared to acidic isocapnia [132]. 
Interestingly, vessel tone was unaltered in response to intraluminal CO2 change, 
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suggesting that a change in superfusate pH is necessary to evoke a change in cerebral 
vascular tone [107, 133]. This is supported by the findings of unchanged CBF in 
humans [107] and animals [133] in response to changes in arterial pH, and highly 
localized pial arteriolar diameter changes in response to the application of acidic/
basic solution into the perivascular space [131]. Additionally, when pH is maintained 
as seen in an experiment with artificial CSF pretreated with sodium bicarbonate, pial 
vessel dilation is eliminated in response to intraluminal hypercapnia [107, 134] further 
supporting that a change in superfusate pH is necessary to alter the cerebral vascular 
tone. In addition to its link with CO2 and H
+ through the carbonic anhydrase reaction, 
there is some evidence that bicarbonate ion may independently influence vascular 
tone. Having the ability to sense and react to multiple parameters associated with 
acidosis allows for control of tone in response to not only the pH but also the cause 
of the disturbance (accumulation of CO2 for instance). In isolated rat basilar arter-
ies reduced [HCO3
−]o has been shown to directly increase cerebral vascular tone 
(with pH maintained at 7.4 and CO2 kept constant at 5%) through the binding of 
receptor protein tyrosine phosphatase through an endothelium-dependent response 
[135]. HCO3
− may, therefore, stimulate soluble adenylate cyclase activity through 
a pH-independent mechanism [136]. If this is correct then the modest increase 
in [HCO3
−] during hypercapnia may aid in the dilation response to CO2 but the 
opposing vasocontractile response to decreases in [HCO3
−]o may limits the vasore-
laxation caused by a reduction in pH [135]. Limiting vasorelaxation during acidosis is 
important to lessen the increase in capillary pressure associated with vasorelaxation of 
upstream arterioles. Hyper-relaxation may overload the capillaries leading to edema 
and damage thereby worsening the consequences of local inadequate perfusion.
4.3 PO2
The effects of oxygen are unique in that its availability is required for aerobic 
metabolism rather than a byproduct like some of the metabolic factors discussed. 
Therefore it is not surprising that its abundance leads to vasoconstriction and its 
relative shortage leads to dilation. Although its availability is tightly linked to that of 
PCO2 and H
+ and other metabolic byproducts in a physiological setting, studies have 
been able to discern its independent effect in the presence of otherwise constant con-
ditions. Data from isolated arteries/arterioles suggest there is in fact an oxygen sensor 
independent of other vasoactive metabolic byproducts within the vascular wall 
itself [137–142]. Once the change in oxygen is sensed there are various mediators of 
hypoxic dilation including endothelial-derived NO [138, 141], prostanoids [137, 140, 
141, 143], 20-HETE [141] and EDHF [139]; however, the contribution of each factor 
appears to be dependent on the severity of hypoxia [141]. In skeletal muscle, dilation 
from mild hypoxia (15% O2) was mostly NO-dependent, while moderate (10% O2) 
was mediated by a combination of increased PGI2 and decreased 20-HETE, and 
severe (0% O2) was almost entirely accounted for by an increase in PGI2 [141]. In all 
cases, there appears to be significant involvement by the endothelium to mediate the 
dilation, which is further supported by a reduction in hypoxic dilation when isolated 
vessels were exposed to indomethacin (an inhibitor of AA metabolism and thus the 
production of PGI2) [137, 144, 145] and to a lesser degree by L-NAME (an inhibitor 
of NO production from NOS) [145]. Therefore, PGI2 is likely a substantial contribu-
tor to hypoxic dilation with a lesser but likely still significant role for NO. Human 
studies measuring CBF with pcMRI, instead of isolated vessel diameter as in the 
aforementioned studies, with and without administration of L-NAME suggest that 
hypoxic dilation is highly dependent on NO, with no change from baseline observed 
in hypoxia when L-NAME was administered [146]. These differences may be 
because of a species-specific response or differences in ex vivo and in vivo conditions. 
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Additional mechanisms of hypoxic dilation include adenosine whose action has 
previously been discussed. In hyperoxic conditions constriction is favored, mediated 
by a greater conversion of AA to 20-HETE as opposed to dilators such as PGI2 [147].
4.4 Potassium and neurovascular coupling
Although K+ is not directly a byproduct of a metabolite pathway it tends 
to increase in concentration when the frequency of neuronal depolarization is 
increased, and is therefore indicative of increased metabolism. K+ channels are 
present in cerebrovascular smooth muscle cells and are important regulators of tone 
because of their ability to alter membrane potential [148, 149]. Although K+ channels 
are present through the peripheral vasculature, the cerebral circulation has a unique 
anatomical feature that allows for intimate interaction of astrocytic endfeet and 
cerebral vessels. This tight interaction between the astrocytic endfeet and vascu-
lature allows for precise localized changes in blood flow to match the site-specific 
neural activity in the brain [150, 151]. K+ can therefore be thought of as a direct link 
between neuronal activity and blood flow. This pairing of neuronal metabolism with 
appropriate blood flow and is termed neurovascular coupling (NVC). NVC forms the 
mechanistic basis for neuroimaging techniques that are able to map changes in neu-
ronal activity based on vascular responses such as changes in blood flow or oxygen 
saturation [152]. As such, an understanding of NVC is not only crucial to understand 
the regulation of cerebral vascular tone but is also needed to interpret these neuroim-
aging techniques including functional magnetic resonance imaging (fMRI), positron 
emission tomography (PET), and near-infrared spectroscopy [153].
NVC is dependent on the interactions of the neurovascular unit which is made 
up of three major components: the vascular smooth muscle, neuron, and astrocyte 
glial cell. Somewhat surprisingly, the initiation site of neurovascular coupling is 
at the level of capillaries which then leads to changes upstream; however, once the 
close anatomical locations of neurons to the capillaries (8–20 μm) are considered 
this becomes a logical point of initiation [154]. Not only does NVC rely on interac-
tions apart from the vasculature but it also requires several structural components 
to facilitate cell-to-cell interactions of these different cell types. These components 
include gap junctions [155, 156], anchoring proteins [157] and specialized ion 
channels [158] expressed on cell–cell interface membranes. Neurons initiate NVC 
by generating direct signals that act on the vasculature and indirect signals that are 
transmitted through astrocytes and lead to increases in intracellular Ca2+ within 
the astrocyte. This is achieved by the glutamatergic synaptic activity initiating 
post-synaptic N-methyl-D-receptors (NMDA) and a-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid (AMPA) receptors. The increase in intracellular Ca2+ 
activates Ca2+-dependent enzymes to produce vasodilators. Some of the enzymes 
activated include neuronal NOS (nNOS) and cyclooxygenase 2 (COX-2) [159, 160]. 
Glutamate also acts on metabotropic glutamate receptors in astrocytes increasing 
Ca2+ in these cells and leading to the production of vasoactive metabolites including 
adenosine, ATP, and K+ that act of the VSMCs [161].
Astrocytes are anatomically well positioned to transmit signals from neurons 
to the vasculature because of their close proximity to the capillaries; however, in 
a vascular network both the downstream and upstream vasculature must work 
in concert in order to effectively regulate blood flow delivery. It appears that 
endothelial cells provide the crucial role of retrograde propagation of the vasomo-
tor response allowing for coordination between up and downstream vasculature. 
Endothelial cells can produce numerous metabolites including NO, prostanoids, 
and endothelin to alter VSMCs constriction. Endothelial intermediate K+ channels 
(KIR) channels and small conductance K
+ channels (KSK) have been implicated as a 
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mechanistic contributor to the propagation of the vasodilatory signal upstream for 
a synchronized hemodynamic response between the capillaries and arterioles via 
myoendothelial gap junctions [162]. Secondary to the movement of hyperpolar-
izing current through gap junctions, K+ efflux from KIR and KSK channels generates 
what has been described as a “K+ cloud” [163] that also hyperpolarizes neighboring 
VSMC through both the inducible Na+-K+ electrogenic pump and stimulation of 
inward rectifying potassium channels in the VSMC of cerebral arteries and arteri-
oles. In both cases, there is a net efflux of K+ from VSMC [164–167] in conjunction 
with closed voltage-gated calcium channels and therefore results in the relaxation 
of the VSMC. The importance of K+ channels in dilating the cerebral vasculature 
is supported by reduced K+ conductance, depolarization and ultimately constric-
tion seen in experimental inhibition of the channels [163]. For example, 6–10 mM 
K+ applied to capillaries generated a hyperpolarizing response in endothelial cells 
which was transmitted upstream to penetrating arterioles hyperpolarizing and 
relaxing VSMCs [168]. This propagation of the vasodilation signal was blocked with 
inhibition of KIR with barium or endothelial deletion of KIR1.2 channels, support-
ing its role transmitting the hyperpolarizing current. Interestingly the capillaries 
themselves did not dilate to K+ suggesting they act as a sensor detecting the signal 
for the upstream arterioles to be the effector of the response [161].
Although in a physiological setting K+ tends to lead to vasodilation, the response 
to K+ may be dependent on the [K+]. In isolated cerebral arterioles low (<7 mM) and 
moderate (8–15 mM) increases in [K+] result in endothelium-independent dilations 
and sustained dilation respectively through mechanisms previously discussed [165]. 
Higher K+ concentrations cause constriction; however, under normal physiologi-
cal conditions this concentration is not reached and is only seen under pathological 
processes such as spreading depression and stroke [169, 170]. This response seen 
in isolated vessel has also been confirmed in vivo [151]. There is a combination of 
mechanisms at work in response to K+ that may explain the opposing responses to 
different concentrations. Alone an increase in [K+]o actually tends to depolarize 
neighboring VSMC resulting in constriction; this response predominates at high [K+]. 
At low concentrations, the minor increase in [K+]o would by itself lead to constriction 
but it also stimulates both KIR channels [150, 171–174] and Na
+/K+ ATPase [175–177] 
promoting K+ efflux as previously described. This description of the electrophysiology 
at work in the VSMC is supported by Em measurement in VSMCs when a solution con-
taining [K+] (<20 mM) is applied and produces VSM hyperpolarization, whereas at 
higher K+ concentrations depolarization predominates [166, 172, 178]. Ultimately the 
signals generated by neurons, astrocytes, and endothelial cells must be received and 
integrated into a final level of tone by the VSMCs. A schematic representation of the 
impact of neurovascular coupling on cerebral vascular tone is presented in Figure 1.
5. Effect of diseased states
Each component implicated in the regulation of tone has a multitude of signals 
being produce that is intended to affect a vasomotor response from the VSMCs. Signals 
from myogenic, shear, metabolic, and neurovascular influences may be additive or 
opposing in their effect on VSMCs and further combine with one another creating 
intricate and precise regulation of cerebral vascular tone. It is this intricacy however, 
that also introduces many possible steps in the pathway for an abnormal response to 
occur. As such changes to the regulation of tone may form the basis of several patholo-
gies including MetS. The contributing risk factors associated with MetS alter the local 
regulation of cerebral vascular tone by inducing changes in both the structure and 
function of the vessels. These risk factors include hypertension, T2DM, and obesity 
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which promote a pro-inflammatory pro-oxidant state. Functionally, MetS is highly 
linked to increased smooth muscle activation and endothelial dysfunction which has 
important implications for the ability of a vessel to dilate in response to a multitude 
of stimuli previously discussed including hypotension, shear, hypoxia, and other 
metabolic stimuli. Increased myogenic properties are consistently overserved in MetS 
in multiple vascular beds [179, 180] including in the cerebral circulation [181–183]. 
This increase in constriction may be due to both a decrease in buffering capacity from 
endothelial dysfunction and alterations in the vascular smooth muscle itself [183, 184]. 
Endothelial dysfunction also has implication for shear-induced dilation since it is highly 
dependent on NO bioavailability which has consistently been shown to be reduced in 
MetS. The chronic inflammatory state seen in MetS likely contributes to the reduction 
in NO bioavailability due to increased scavenging to the produced NO by reactive 
oxygen species since this reduction in NO bioavailability is consistently reported to 
evolve in parallel with oxidant stress and the development of a chronic inflammatory 
state [185, 186]. This is supported by improved dilatory reactivity of MCA with the 
pretreatment of the cell-permeable superoxide dismutase mimetic TEMPOL in a model 
of T2DM [145]. Interestingly some studies have actually shown an increase in eNOS 
expression which may be an attempt to compensate for the increased scavenging; 
however, they too continue to find reduced dilator reactivity [187].
Aside from reduced NO bioavailability, a shift in arachidonic acid metabolism 
toward constrictors and away from dilators that are highly responsible for hypoxic 
dilation has been demonstrated [145]. Thus not only does endothelial dysfunction 
seen in MetS increase cerebrovascular resistance by decreased dilator metabolite 
production it may also promote the production of constrictors that exacerbate the 
impaired dilation capacity of cerebral vessels [184, 188]. A change in sensitivity to 
various metabolites in addition to their differential production may also contribute 
to differential vasomotor responses. For example, studies using SNP, an exogenous 
NO donor, while blocking endogenous NO production by eNOS using L-NAME, 
found smaller relaxation of the MCA in spontaneously hypertensive rats which was 
attributed to a decreased expression of soluble guanylate cyclase [189–192]. In a 
model of T2DM decreased sensitivity of MCA to the PGI2 analog iloprost was also 
found suggesting that both decrease production and sensitivity of dilators may be 
contributing to the impaired dilation of the cerebral circulation in MetS [145].
Impaired dilation in response to exogenous dilator metabolites may also be due to 
vascular remodeling. Structural changes are an important consideration since even 
if the smooth muscle of a cerebral vessel is able to relax due to metabolic influences 
resulting in hyperpolarization, remodeling may prevent an increase in lumen diameter 
which is ultimately the major contributor to acute changes in resistance and thus the 
regulator of flow. Hypertension is largely implicated in the thickening of the vascular 
smooth muscle as well as increasing the ratio of collagen to elastin in the vessel. High 
intraluminal pressure increases the shear stress exerted on the vascular endothelium 
which normally could be restored to baseline by NO-induced vasodilation [193–195]; 
however, in a disease state with impaired NO production, there is a reduced ability to 
dilate resulting in endothelial damage and upregulation of atherogenic genes [193–195]. 
As a means of protection from chronic increased shear stress and wall tension that may 
lead to downstream edema cerebral vessels tend to hypertrophy with chronic hyperten-
sion, but this protective hypertrophy is also detrimental [188]. Since wall tension is 
equal to intraluminal pressure X radius and wall stress is wall tension/wall thickness, 
hypertension-induced hypertrophy and inward remodeling resulting in a decrease in 
radius and increase wall thickness can normalize both the wall tension and wall stress 
[188]. Although this remodeling may be protective in regards to increases in pressures 
and protecting the downstream capillaries from edema it increases the cerebrovascular 
resistance and limits the dilation reserve during hypotension and therefore presents 
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itself as a right-shift in the autoregulatory range [196, 197]. The development of myo-
genic tone at higher pressure implies an increased lower limit of autoregulation. This 
predisposes cerebral tissue to reduced blood flow during hypotension. When pressure 
drops below the lower limit flow becomes dependent on the passive diameter of the 
vessel. Not only does an impaired lower limit predispose hypertensive individuals to 
ischemia but the reduced passive diameter from vascular remodeling further compro-
mises flow to cerebral tissue resulting in hypoxic areas [43].
In addition to hypertrophy and inward remodeling, there is substantial arterial 
stiffening commonly seen in MetS. The pro-oxidant stress of ROS may interact 
with components of the perivascular matrix and initiate collagen cross-linking and 
deposition as well as the breakdown of elastin making the vessel less distensible 
[198]. This is measured by a left shift in the stress-strain curve of isolated cerebral 
vessels under passive conditions achieved by using a Ca2+ free solution preventing 
the development of tone [183]. The stiffening vessel from increased collagen to 
elastin ratio is made worse by the thickening of vessel walls previously discussed. 
In a model of T2DM with hypertension significant collagen deposition in addition 
to medial hypertrophy increasing the wall the lumen ratio and stiffness of the rats 
MCA [199] was demonstrated while T2DM in the absence of hypertension does 
not appear to induce structural changes to the cerebral vasculature [145]. This 
along with data that suggests the increase in arterial stiffness seems to follow a time 
course similar to that of the onset of hypertension suggests a strong relationship 
between hypertension and vascular remodeling [200]. Chronic uncontrolled hyper-
glycemia and inflammation do tend to lead to the development of hypertension and 
thus contribute to changes in the composition of cerebral vessels and it is likely the 
combination of both seen in MetS increases the degree to which remodeling occurs. 
A summary of the impact of disease states on the regulation of cerebral vascular 
tone is presented in Figure 2.
Figure 2. 
A schematic representation of how the presence of metabolic syndrome and the major constituent pathologies 
can impact the integrated regulation of cerebral vascular tone.
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6. Conclusions
In conclusion, the regulation of vascular tone involves a complex set of pathways 
with myogenic, shear, and metabolic control. The mechanical influences of pressure 
and flow serve as a stimulus for the myogenic and shear responses to set a basal level 
of tone over a wide range so that metabolic factors have room to produce vasoactive 
responses on the vasculature. Due to the paramount importance of precise cerebral 
blood flow control these mechanisms are particularly pronounced and redundant in 
the cerebral circulation allowing for greater protection against insufficient perfu-
sion or edema and capillary damage in situations of hypotension and hypertension 
respectively. However, due to the complexity of these homeostatic blood flow 
mechanisms there is the potential for the development of a pathological state. MetS 
presents a constellation of cardiovascular risk factors that are highly linked to the 
development of such cerebrovascular pathologies increasing the risk of stroke, TIA, 
and vascular dementia. The risk factors associated with MetS result in vascular 
remodeling which decreases the lumen size and increases stiffness and when paired 
with endothelial dysfunction and increased activation of the vascular smooth 
muscle it promotes increased cerebrovascular resistance. This right shifts the 
autoregulatory zone of myogenic regulation allowing for enhanced protection from 
hypertension but leaves cerebral tissue vulnerable to underperfusion. Controlling 
these risk factors and well as implementing targeted therapeutic strategies aimed 
at ameliorating the regulation of cerebrovascular tone has the potential to restore 
function in the cerebral circulation and improve current negative outcomes associ-
ated with MetS and cerebrovascular dysfunction.
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